Your browser doesn't support javascript.
loading
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.
Luengo-Fernandez, Ramon; Penz, Erika; Dobson, Melissa; Psallidas, Ioannis; Nunn, Andrew J; Maskell, Nick A; Rahman, Najib M.
Afiliação
  • Luengo-Fernandez R; Health Economics Research Centre, Nuffield Dept of Population Health, University of Oxford, Oxford, UK.
  • Penz E; Dept of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.
  • Dobson M; Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK.
  • Psallidas I; Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK.
  • Nunn AJ; MRC Clinical Trials Unit, University College London, London, UK.
  • Maskell NA; Academic Respiratory Unit, Bristol Medical School, University of Bristol, Bristol, UK.
  • Rahman NM; Oxford Respiratory Trials Unit, Nuffield Dept of Clinical Medicine, University of Oxford, Oxford, UK najib.rahman@ndm.ox.ac.uk.
Eur Respir J ; 54(2)2019 08.
Article em En | MEDLINE | ID: mdl-31097519

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pleura / Ativador de Plasminogênio Tecidual / Desoxirribonucleases / Pneumopatias Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pleura / Ativador de Plasminogênio Tecidual / Desoxirribonucleases / Pneumopatias Tipo de estudo: Clinical_trials / Health_economic_evaluation Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article